The Copay is Right: The Tipline for 29 August 2023
Bob Barker’s legendary The Price Is Right would never have spanned 35 years had the show dealt with pharmaceutical prices instead of brick-and-mortar items. How can the public be expected to play along at home when rebates, the Hatch-Waxman Act, PBMs and insurance providers are muddying the field? In today’s Tipline, the Federal Trade Commission loses a pay-for-delay case and it may be close to settling its first effort to block a pharmaceutical merger in 14 years.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10